Maurício Dener Cordeiro

Maurício Dener Cordeiro

Auto-generated profile, based on publicly available information

Maurício Dener Cordeiro

Division of Urology, Instituto do Câncer do Estado de São Paulo (ICESP), Universidade de São Paulo (USP), São Paulo, SP, Brazil

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2014 in BJU International
Verified
Journal Article
Open access
PDF file
MCMaurício D. Cordeiro
Maurício D. Cordeiro
RCRafael F. Coelho
Rafael F. Coelho
DCDaher C. Chade
Daher C. Chade
RPRodrigo R. Pessoa
Rodrigo R. Pessoa
MCMateus S. Chaib
Mateus S. Chaib
MSMiguel Srougi
Miguel Srougi
Objective: To identify factors associated with survival after palliative urinary diversion ( UD ) for patients with malignant ureteric obstruction ( MUO ) and create a risk‐stratification model for treatment decisions. Patients and Methods: We prospectively collected clinical and laboratory data for patients who underwent palliative UD by ureteric stenting or percutaneous nephrostomy ( PCN ) between 1 J anuary 2009 and 1 N ovember 2011 in two tertiary care university hospitals, with a minimum 6‐month follow‐up. Inclusion criteria were age >18 years and MUO confirmed by computed tomography, ultrasonography or magnetic resonance imaging. Factors related to poor prognosis were identified by C ox univariable and multivariable regression analyses, and a risk stratification model was created by K aplan– M eier survival estimates at 1, 6 and 12 months, and log‐rank tests. Results: The median (range) survival was 144 (0–1084) days for the 208 patients included after UD (58 ureteric stenting, 150 PCN ); 164 patients died, 44 (21.2%) during hospitalisation. Overall survival did not differ by UD type ( P = 0.216). The number of events related to malignancy (≥4) and E astern C ooperative O ncology G roup ( ECOG ) index (≥2) were associated with short survival on multivariable analysis. These two risk factors were used to divide patients into three groups by survival type: favourable (no factors), intermediate (one factor) and unfavourable (two factors). The median survival at 1, 6, and 12 months was 94.4%, 57.3% and 44.9% in the favourable group; 78.0%, 36.3%, and 15.5% in the intermediate group; and 46.4%, 14.3%, and 7.1% in the unfavourable group ( P < 0.001). Conclusions: Our stratification model may be useful to determine whether UD is indicated for patients with MUO .

1 April 2022 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
MCMauricio Dener Cordeiro
Mauricio Dener Cordeiro
EIEder Nisi Ilario
Eder Nisi Ilario
DADaniel Kanda Abe
Daniel Kanda Abe
PCPaulo Afonso de Carvalho
Paulo Afonso de Carvalho
DMDavid Queiroz Borges Muniz
David Queiroz Borges Muniz
WNWilliam Carlos Nahas
William Carlos Nahas

1 February 2022 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
KLKatia Ramos Moreira Leite
Katia Ramos Moreira Leite
LBLeonardo Lima Borges
Leonardo Lima Borges
LFLeopoldo Ribeiro Filho
Leopoldo Ribeiro Filho
DCDaher Chade
Daher Chade
RCRafael Ferreira Coelho
Rafael Ferreira Coelho
WNWillian Carlos Nahas
Willian Carlos Nahas

1 February 2024 in BJUI Compass
Verified
Journal Article
Open access
CSCaio Vinicius Suartz
Caio Vinicius Suartz
LMLucas Motta Martinez
Lucas Motta Martinez
PBPedro Henrique Brito
Pedro Henrique Brito
CNCarlos Victori Neto
Carlos Victori Neto
MCMaurício Dener Cordeiro
Maurício Dener Cordeiro
LRLeopoldo Alves Ribeiro‐Filho
Leopoldo Alves Ribeiro‐Filho
Introduction: Surgical intervention is the treatment of choice in patients with urachal carcinoma. Due to complications and to reduce hospital stay from open surgery, minimally invasive approaches are desirable. Nowadays, robotic‐assisted surgery has become increasingly popular, and robot‐assisted cystectomy can be performed in patients with urachal carcinoma with low complication rates.Methods: We performed a systematic review to search for studies that evaluated patients who underwent robotic‐assisted surgery for urachal carcinoma. The outcomes of interest were the type of cystectomy performed, whether there was umbilicus resection, total operative time, console time, intraoperative complications, estimated blood loss, postoperative complications, time of hospitalisation, positive surgical margins and the presence of documented tumour recurrence.Results: In this study, we evaluated three cohorts comprising a total of 21 patients. The median follow‐up period ranged from 8 to 40 months. Medium age was between 51 and 54 years, with a majority (63.1%) being male. One patient (5.2%) underwent a radical cystectomy, and 19 patients (94.7%) underwent to partial cystectomy. Umbilical resections were performed in all cases, and pelvic lymphadenectomy in 14 cases (73.6%). Recurrence occurred in three patients at a median of 17 months postoperation, two cases in the trocar insertion site. Additionally, there was one death, which was attributed to postoperative cardiovascular complications.Conclusion: Robotic‐assisted partial cystectomy has a low incidence of adverse outcomes in patients with urachal carcinoma. Controlled studies, ideally randomised, are warranted to establish the comparative efficacy and safety of the robotic‐assisted cystectomy approach relative to open surgery.

2 November 2024 in World Journal of Urology
Verified
Journal Article
Closed access
PDF file
LCLeonardo Cardili
Leonardo Cardili
DBDiogo Assed Bastos
Diogo Assed Bastos
EIEder Nisi Ilario
Eder Nisi Ilario
Marina Alessandra PereiraMarina Alessandra Pereira
Marina Alessandra Pereira
GGGiuliano Betoni Guglielmetti
Giuliano Betoni Guglielmetti
KLKatia Ramos Moreira Leite
Katia Ramos Moreira Leite

29 May 2024 in Clinical Genitourinary Cancer
Verified
Journal Article
Closed access
CSCaio Vinicius Suartz
Caio Vinicius Suartz
PSPedro Antonio Araújo Simões
Pedro Antonio Araújo Simões
NBNatália Doratioto Serrano Faria Braz
Natália Doratioto Serrano Faria Braz
FSFlávio Rossi da Silva
Flávio Rossi da Silva
RURobson Uwagoya
Robson Uwagoya
LRLeopoldo Alves Ribeiro-Filho
Leopoldo Alves Ribeiro-Filho